News | August 13, 2007

C4 Predicts Stroke in Patients with CAD

August 14, 2007 - Baseline serum complement component C4 is among independent predictors of stroke in patients with known or suspected coronary artery disease.

"What we have shown," lead investigator Dr. Erdal Cavusoglu told Reuters Health, "is that the complement components C3 and C4 were independent predictors of the future development of stroke in a broad and heterogenous population of patients who were referred for coronary angiography. C4 seemed slightly stronger than C3."

In the July 15th issue of the American Journal of Cardiology, Dr. Cavusoglu of Bronx Veterans Affairs Medical Center, New York and colleagues note that there is some data in the literature on C3 in prediction of stroke, but none for C4.

To investigate further, the researchers studied 389 men referred for angiography for a variety of indications.

During 24 months of follow-up, there were 23 strokes and elevated baseline C4 was an independent risk factor for such an event (hazard ratio 1.57).

Stroke-free survival in subjects whose C4 levels were at or below the median was 96.1 percent. For those with higher levels, it was 90.1 percent.

The researchers also found that established markers such as erythrocyte sedimentation rate and baseline levels of fibrinogen and high-sensitivity C reactive protein were predictive of stroke.

However, concluded Dr. Cavusoglu, "the finding that C4 predicted risk independently from these nonspecific markers of inflammation, suggests that measurement of C4 may add prognostic value above and beyond markers of acute-phase response in patients with known or suspected coronary artery disease."

Source: Reuters
Author: David Douglas

For more information:

Related Content

Florida Medical Center First in State to Offer High Sensitive STAT Blood Test
News | Blood Testing| September 07, 2017
In July, The Heart Institute at Florida Medical Center became the first hospital in the state of Florida to offer the U...
Patients With Low Corus CAD Test Score Less Likely to Undergo Cardiac Referra
News | Blood Testing| May 02, 2017
CardioDx Inc. recently announced the publication of results from the multi-center, community-based PRESET Registry in...
New Blood Test Predicts Major Cardiac Events Better Than Clinical Evaluation of Other Common Risk Factors
News | Blood Testing| April 28, 2017
Prevencio Inc. announced the publication of data demonstrating that a simple new blood test is more accurate than...
New Study Pursues Universal Sample Bank for Troponin Tests
News | Blood Testing| April 13, 2017
April 13, 2017 — A study published recently in the American Association for Clinical Chemistry’s (AACC)...
PTS Diagnostics, FDA 510k clearance, extended HDL range, lipid panel test strips
News | Blood Testing| April 05, 2017
PTS Diagnostics announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded top range for...
heart attack evaluation, blood test, HEART Score, ER, emergency room, Circulation Cardiovascular Quality and Outcomes study
News | Blood Testing| March 01, 2017
Up to 40 percent of emergency room (ER) patients with chest pain can safely go home in a little under 2 hours, using a...
troponin blood test, heart disease risk, heart attack, British Heart Foundation, BHF
News | Blood Testing| January 04, 2017
A high-sensitivity blood test could be used to predict which patients are at risk of a heart attack according to new...
Alere, INRatio PT/INR Monitor, voluntary recall, FDA
News | Blood Testing| July 12, 2016
July 12, 2016 — Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc.
News | Blood Testing| March 22, 2016
March 22, 2016 — Critical Diagnostics announced that it entered into a license agreement for the exclusive worldwide
Overlay Init